The deal, gives Merck access to SPR2015, an oral drug candidate targeting KRAS G12D, one of the most common cancer-driving ...
Novo Nordisk secures licensing rights to Hengrui's experimental GLP-1 pill for weight management, enhancing its portfolio in ...
Swiss pharmaceutical leader Roche reveals ambitious plans to establish autonomous AI labs aimed at expediting research and ...
Explore how new cholesterol-lowering therapies, including PCSK9 inhibitors and oral options, are changing the landscape of ...
A federal judge has rejected efforts by Pfizer, BioNTech, and Moderna to dismiss Bayer's patent lawsuit related to mRNA technology used in COVID-19 vaccines. This ruling highlights ongoing legal ...
BioNTech, the German COVID-19 vaccine maker, is set to close its sites in Germany and Singapore after failing to secure ...
India Ratings and Research forecasts a 10% growth for the Indian pharmaceutical industry in FY27, supported by strong ...
Sanofi Healthcare India purchases a 15.2% stake in Sanofi India, boosting its investment in the pharmaceutical giant. The ...
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued the revised guidelines for obtaining No Objection Certificate to export approved and unapproved new drugs from the country ...
Sun Pharmaceuticals acquires rights to manufacture and market Lyrokaul, a novel PCSK9 inhibitor, enhancing treatment options for cholesterol management. Discover its benefits and market implications.
The decision followed discussions with the US Food and Drug Administration, which determined that the data from a mid-stage ...
Eli Lilly has gained FDA approval for Olumiant to treat severe alopecia areata in children aged 12 and over, marking a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results